Expansion Opportunity Centricity Research has aggressively expanded through strategic acquisitions, notably Lucas Research, signaling a growth trajectory and potential for cross-sell of higher-end CRO services, data management, and site network capabilities to add-on clients and therapeutic areas.

Financial Strength With reported revenue between 250M and 500M and a leadership transition including a new CEO and CFO, there is appetite for strategic partnerships, co-development arrangements, and scalable outsourcing deals that leverage their scale while managing risk.

Therapeutic Breadth Operating in over 35 therapeutic areas across Phase I-IV trials creates opportunities to position Centricity as a preferred full-service partner for sponsors seeking a broad, integrated trial network and diverse treatment expertise.

Network Reach A North American footprint of more than 40 wholly owned and integrated clinical research offices enhances access to diverse patient populations and site-level collaboration, enabling multi-site sponsor programs and faster recruitment strategies.

Innovation & Awards Recognition for best places to work and diversity in clinical research underscores a strong culture and talent attraction, presenting an avenue to discuss co-development, patient-centric trial design, and vendor partnerships focused on quality and inclusive research.